MONTREAL, CANADA--(Marketwire - May 06, 2008) - ART Advanced Research Technologies Inc. (“ART”) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that on Wednesday, May 7, 2008, Mr. Sebastien Gignac, ART’s President and Chief Executive Officer, will present an update on the Company’s recent developments at the BioFinance investor conference to be held at the Toronto Marriott Eaton Centre Hotel, located at 525 Bay Street in Toronto, Canada. Mr. Gignac’s presentation will take place at 9:30 a.m. (EST) in the Trinity II room.
